trial

Randomized multicenter trial of a bionic pancreas in type 1 diabetes |  NEJM

Randomized multicenter trial of a bionic pancreas in type 1 diabetes | NEJM

The full names and academic degrees of the authors are as follows: Steven J. Russell, MD, Ph.D., Roy W. Beck, MD, Ph.D., Edward R. Damiano, Ph.D., Firas H. El-Khatib, Ph.D., Katrina J. Ruedy, MSPH, Courtney A. Balliro, RN, CDCES, CRN-BC, Zoey Li, MS, Peter Calhoun, Ph.D., R. Paul Wadwa, MD, Bruce Buckingham, MD, Keren Zhou, …

Randomized multicenter trial of a bionic pancreas in type 1 diabetes | NEJM Read More »

Alzheimer's disease drug slows progression of cognitive decline in clinical trial, drugmakers say |  CNN

Alzheimer’s disease drug slows progression of cognitive decline in clinical trial, drugmakers say | CNN

CNN — A monoclonal antibody treatment for Alzheimer’s disease called lecanemab slows the progression of cognitive decline by 27% compared to a placebo, drugmakers Biogen and Eisai said on Tuesday. The drug, tested in a global Phase 3 clinical trial, also met all secondary endpoints, showing “target engagement” with reduced levels of amyloid – a …

Alzheimer’s disease drug slows progression of cognitive decline in clinical trial, drugmakers say | CNN Read More »

Alzheimer's disease treatment slowed cognitive decline in closely monitored clinical trial

Alzheimer’s disease treatment slowed cognitive decline in closely monitored clinical trial

An Biogen and Eisai’s experimental Alzheimer’s disease treatment slowed the rate of cognitive decline by 27% in a clinical trial, the companies said on Tuesday, meeting the goals of a closely watched study and bolstering the case of the drug for approval as early as January. The positive result is good news for the millions …

Alzheimer’s disease treatment slowed cognitive decline in closely monitored clinical trial Read More »

Experimental Alzheimer's drug slows cognitive decline in trial, companies say

Experimental Alzheimer’s drug slows cognitive decline in trial, companies say

An experimental drug for Alzheimer’s disease slowed cognitive and functional decline by 27% in a closely monitored clinical trial, the drug’s sponsors said on Tuesday, boosting the therapy’s chances of approval earlier this year. next. Japanese drugmaker Eisai and its US partner, Biogen, said in a press release that the slowing of deterioration, compared to …

Experimental Alzheimer’s drug slows cognitive decline in trial, companies say Read More »

Two Popular Diabetes Drugs Outperformed Others in Massive Clinical Trial

Two Popular Diabetes Drugs Outperformed Others in Massive Clinical Trial

Press release Wednesday, September 21, 2022 NIH-funded researchers complete first study comparing drugs commonly used for type 2 diabetes. In a large clinical trial directly comparing four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide were the best of the four drugs approved by the United States Food …

Two Popular Diabetes Drugs Outperformed Others in Massive Clinical Trial Read More »

Lupus patients go into remission in 'spectacular' immunotherapy trial

Lupus patients go into remission in ‘spectacular’ immunotherapy trial

Five critically ill lupus patients saw their disease go into remission after a single infusion of modified immune cells, in a small trial that borrows from cancer therapy to harness patients’ own cells to treat the autoimmune disease . Scientists are call the “dramatic” and “incredibly exciting” results, saying the findings could herald a new …

Lupus patients go into remission in ‘spectacular’ immunotherapy trial Read More »

Brett Favre in February 2022.

Brett Favre’s Texts in Mississippi Welfare Scandal, Final Trial

Mississippi State is suing former NFL quarterback and Hall of Famer Brett Favre and others, alleging they misspent millions of dollars that were earmarked for welfare. Newly revealed text messages from 2017 indicate that former Mississippi Governor Phil Bryant, who left office in 2020, knew about the arrangement and that the money was intended to …

Brett Favre’s Texts in Mississippi Welfare Scandal, Final Trial Read More »

Nikola founder Trevor Milton stands trial for fraud, capping stunning rise and fall

Nikola founder Trevor Milton stands trial for fraud, capping stunning rise and fall

US Nikola CEO and Founder Trevor Milton speaks during the presentation of his new all-electric battery-powered and hydrogen fuel cell trucks in partnership with CNH Industrial, at an event in Turin, Italy, on December 2, 2019. Massimo Pinca | Reuters The founder of electric tractor-trailer maker Nikola Motor is on trial on fraud charges related …

Nikola founder Trevor Milton stands trial for fraud, capping stunning rise and fall Read More »

New cell therapy for melanoma more effective than existing treatment, trial finds

New cell therapy for melanoma more effective than existing treatment, trial finds

European researchers announced on Saturday that a new treatment for advanced melanoma was more effective than the existing main therapy in a phase 3 clinical trial. The treatment, which uses a patient’s own immune cells to fight the cancer, has some similarities to another type of treatment that has been shown to be very effective …

New cell therapy for melanoma more effective than existing treatment, trial finds Read More »